Vineet Laboratories

Vineet Laboratories EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vineet Laboratories (VINEETLAB.NS) as of Nov 10, 2026 is 60.64 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -162.83 M INR — a change of -137.24% (higher).

EBITDA

60.64 MINR

YoY

-137.24%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vineet Laboratories is 2026 60.64 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vineet Laboratories was 2025 -162.83 M INR. It decreases by -137.24% higher compared to the previous year.

The Vineet Laboratories EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2020
-111,020.00 INR
Jan 1, 2021
81.49 M INR
Jan 1, 2022
131.66 M INR
Jan 1, 2023
80.88 M INR
Jan 1, 2024
72.00 M INR
Jan 1, 2025
-162.83 M INR
Jan 1, 2026
60.64 M INR
The Vineet Laboratories EBITDA history
YEAREBITDAYoY
60.64 MINR-137.24%
-162.83 MINR-326.15%
72.00 MINR-10.98%
80.88 MINR-38.57%
131.66 MINR+61.57%
81.49 MINR-73,502.09%
-111,020.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vineet Laboratories Stock analysis

What does Vineet Laboratories do? Vineet Laboratories Ltd is a Hyderabad-based company operating in the Health Care sector, specifically within the pharmaceutical industry. Listed on the Indian stock exchange in June 2021, the firm specializes in the production and export of pharmaceutical intermediates and fine chemicals. Its portfolio of active pharmaceutical ingredient intermediates includes Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Additionally, the company manufactures various fine chemicals and reagents such as Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, and n-Butyl Lithium. Vineet Laboratories also offers custom synthesis molecules to international markets. Vineet Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vineet Laboratories stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vineet Laboratories is 60.64 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vineet Laboratories changed from -162.83 M INR to 60.64 M INR, representing a -137.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Vineet Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Vineet Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vineet Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vineet Laboratories